Shimano, K. A., Grimes, A. B., Rose, M. J., Kaicker, S., Shah, S. J., Briones, M., … Grace, R. F. (2024). Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children. In Blood (Vol. 144, pp. 709–709). American Society of Hematology. https://doi.org/10.1182/blood-2024-193644

Shimano, Kristin A., Amanda B. Grimes, Melissa J. Rose, Shipra Kaicker, Sanjay J. Shah, Michael Briones, Elizabeth Gunn, et al. “Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children.” In Blood, 144:709–709. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-193644.

Shimano KA, Grimes AB, Rose MJ, Kaicker S, Shah SJ, Briones M, et al. Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children. In: Blood. American Society of Hematology; 2024. p. 709–709.

Shimano, Kristin A., et al. “Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 709–709. Crossref, doi:10.1182/blood-2024-193644.

Shimano KA, Grimes AB, Rose MJ, Kaicker S, Shah SJ, Briones M, Gunn E, Nakano TA, Lebensburger JD, Lambert MP, Fritch Lilla SA, Jesudas R, Lee-Miller CA, Thompson A, Bhat R, Rifkin-Zenenberg S, Majumdar S, Kochhar M, Crary SE, Hege K, Rothman JA, Ford JB, Bies JJ, Fort J, Hsieh L, Ruiz ME, Carrier KM, Dinu B, Wong JMW, Kao P-C, London WB, Arnold SD, Bennett CM, Despotovic J, Klaassen RJ, Neufeld EJ, Neunert CE, Grace RF. Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children. Blood. American Society of Hematology; 2024. p. 709–709.